Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 20,068 shares at $15.57 ($312K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Seasonal sale ($312k) by CHIEF EXECUTIVE OFFICER — this insider has traded KALV in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.57 | 10,034 | $156K | 50.0% |
| 2 | $15.57 | 10,034 | $156K | 50.0% |
| Total | $15.57 avg | 20,068 | $312K | 100% |
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-04-20 | $193K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |